Switch to:
More From Other Websites
Hedge Funds Are Buying Perrigo Company plc Ordinary Shares (PRGO) Dec 01 2016
What Do Analysts Have to Say about Mallinckrodt? Nov 29 2016
Post Earnings Coverage as Perrigo Q3 Results Beat Expectations Nov 21 2016
[$$] Starboard Value Ponders Perrigo Assets Nov 19 2016
NYPD Union Goes After Drug Prices Amid DOJ Pharma Probe Nov 17 2016
Jeffrey Smith's Starboard Value Discloses Major Stake in Perrigo (PRGO) Nov 16 2016
Perrigo Co. Plc breached its 50 day moving average in a Bullish Manner : PRGO-US : November 15, 2016 Nov 15 2016
ETFs with exposure to Perrigo Co. Plc : November 14, 2016 Nov 14 2016
What did hedge funds trade in Q3? Nov 14 2016
Perrigo Co. Plc :PRGO-US: Earnings Analysis: Q3, 2016 By the Numbers : November 11, 2016 Nov 11 2016
Perrigo upgraded by BofA/Merrill Nov 11 2016
Edited Transcript of PRGO earnings conference call or presentation 10-Nov-16 1:30pm GMT Nov 10 2016
Stocks to Watch: Macy's, Hilton and Kohl's Nov 10 2016
Perrigo (PRGO) Beats on Q3 Earnings, Revenues; View Intact Nov 10 2016
[$$] Perrigo Considering Strategic Alternatives for MS Drug Nov 10 2016
Perrigo to review options for Multiple Sclerosis drug Tysabri Nov 10 2016
PERRIGO CO PLC Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Nov 10 2016
Q3 2016 Perrigo Company PLC Earnings Release - Before Market Open Nov 10 2016
Perrigo Takes Waterland to Arbitration Over Omega Pharma Acquisition Nov 10 2016
Perrigo reports 3Q loss Nov 10 2016
Perrigo reports 3Q loss Nov 10 2016
Perrigo to review options for multiple sclerosis drug royalties Nov 10 2016
Perrigo to review options for multiple sclerosis drug royalties Nov 10 2016
Perrigo Company plc Reports Third Quarter 2016 Financial Results Nov 10 2016
Perrigo Company plc Announces Appointment of Two New Independent Directors to Board Nov 10 2016
Perrigo Company plc Reports Third Quarter 2016 Financial Results Nov 10 2016
Perrigo Company plc Announces Quarterly Dividend Nov 08 2016
Perrigo Company plc to Release Third Quarter Calendar Year 2016 Results on November 10, 2016 Oct 26 2016
Perrigo Invests In Tarex® Patented Technology, As A Key Investment In The Fight Against... Sep 27 2016
Asian stocks advance after worries over Fed rate hike ease Sep 12 2016
Business Highlights Sep 12 2016
Starboard buys stake in drugmaker Perrigo, wants shakeup Sep 12 2016
Perrigo Acknowledges Receipt Of Letter From Starboard Value LP Sep 12 2016
Perrigo Company to Present at Upcoming Investor Conferences Sep 07 2016
Perrigo Announces Tentative FDA Approval For Generic Version Of Epiduo® Gel Sep 01 2016
Perrigo Announces Tentative FDA Approval For Generic Version Of Suprep® Oral Solution And Confirms... Aug 23 2016
Perrigo to Acquire U.S. Distributor of Healthcare & Consumer Goods Products, Geiss, Destin & Dunn Aug 17 2016
Perrigo Company plc Reports Second Quarter 2016 Financial Results Aug 10 2016
Perrigo misses 2Q profit forecasts Aug 10 2016
Perrigo Completes The Divestiture Of Its Vitamins, Minerals & Supplements Business To IVC Aug 08 2016
Perrigo Company plc Announces Quarterly Dividend Aug 02 2016
Perrigo Company plc To Release Second Quarter Calendar Year 2016 Results On August 10, 2016 Jul 27 2016
Perrigo Announces FDA Clearance And Launch Of Non-GMO* Infant Formulas For The U.S. Store Brand... Jun 21 2016
Perrigo Divests Vitamins, Minerals & Supplements Business To IVC Jun 20 2016
Perrigo Announces FDA Approval Of The Generic Version Of Ofirmev® Acetaminophen Injection Jun 16 2016
Perrigo Company to Present at the Oppenheimer 16th Annual Consumer Conference Jun 16 2016
Perrigo Confirms First To File Patent Challenge For Generic Version Of Picato® Gel (0.015% And... Jun 13 2016
Perrigo Announces FDA Approval And Launch Of The Store Brand Equivalent To Flonase® May 31 2016
Valeant appoints Tyco's Sam Eldessouky corporate controller May 26 2016
Perrigo reports 1Q loss May 12 2016
Asian stocks drop ahead of central bank meetings Apr 25 2016
Valeant Pharma picks Perrigo leader to become next CEO Apr 25 2016
Report: Valeant finalizing contract with Perrigo's CEO Apr 22 2016
Drugmaker Perrigo expects $100 million boost from new Israeli plant Mar 02 2016
Perrigo reports 4Q loss Feb 18 2016
Steven A. Cohen accepts two-year SEC ban on outside money Jan 08 2016
AstraZeneca sells U.S. drug rights to Perrigo for $380 million Nov 23 2015
Perrigo to go it alone; shareholders reject $26B Mylan bid Nov 13 2015
Shareholders of drugmaker Perrigo shut the door on Mylan and its $26B, hostile takeover bid Nov 13 2015
Mylan's tender offer for Perrigo unlikely to succeed - sources Nov 12 2015
Mylan-targeted Perrigo held merger talks with Endo - sources Nov 12 2015
FTC clears Mylan's $27B proposed takeover of Perrigo Nov 03 2015


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK